Table 6. Currently studies results of IM-SLNB.
| First author | Year | Case | IM-SLN visualization % (Case) | IM-SLNB success % (Case) | IMLN positive % (Case) |
|---|---|---|---|---|---|
| Dupont [22] | 2001 | 1470 | 2.4 (36) | 100 (36) | 13.9 (5) |
| van der Ent [23] | 2001 | 256 | 25.4 (65) | 63.1 (41) | 26.8 (11) |
| Paganelli [24] | 2002 | 400 | 15.8 (63) | 93.7 (59) | 8.5 (5) |
| Estourgie [25] | 2003 | 691 | 21.7 (150) | 86.7 (130) | 16.9 (22) |
| Farru's [26] | 2004 | 225 | 8.8 (20) | 70.0 (14) | 14.3 (2) |
| Hong [27] | 2005 | 979 | 14.1 (138) | 100 (138) | 18.1 (25) |
| Carcoforo [28] | 2006 | 741 | 14.4 (107) | 60.7 (65) | 15.4 (10) |
| Leidenius [29] | 2006 | 984 | 14.0 (138) | 87.7 (121) | 14.9 (18) |
| Madsen [30] | 2007 | 506 | 21.5 (109) | 78.0 (85) | 23.5 (20) |
| Heuts [5] | 2009 | 1008 | 19.4 (196) | 70.9 (139) | 22.3 (31) |
| Bourre [31] | 2009 | 622 | 28.0 (174) | 92.5 (161) | 11.1 (18) |
| Postma [4] | 2012 | 493 | 24.1 (119) | 72.3 (86) | 16.3 (14) |
| Ozmen [32] | 2015 | 890 | 8.1 (72) | 100 (72) | 13.9 (10) |